from Stocks-Markets-Economic Times https://ift.tt/2Tcf8zZ
Home »
Stocks-Markets-Economic Times
» PharmEasy gets $300 million booster shot for Thyrocare deal
PharmEasy gets $300 million booster shot for Thyrocare deal
from Stocks-Markets-Economic Times https://ift.tt/2Tcf8zZ
Related Posts:
SGX Nifty up 40 points; here's what changed for market while you were sleepingNifty futures on the Singapore Exchange traded 42 points, or 0.38 per cent higher at 10,953.50, in signs that Dalal Street was headed for a positive start on Tuesday. from Stocks-Markets-Economic Times https://ift.tt/2XrzYdz… Read More
Mahindra identifies 9 ‘inhouse unicorns’ for growth, listingMahindra confirmed that the timeframe for initial public offerings of the in-house unicorns is over the next two to five years. These businesses “have created strong capabilities that can provide a platform for significant gr… Read More
Asia stocks rise as upbeat factory data lifts confidenceMSCI's broadest index of Asia-Pacific shares outside Japan rose 0.9%, while shares in China nudged up 0.1%. Australian stocks gained 2% for the biggest intraday gain since July 21. Tokyo shares also jumped by more than 1%. f… Read More
Tata Motors to drive in foreign partner in India passenger car businessThe move to bring in a strategic partner in the India car business comes 12 years after Tata Motors acquired Jaguar Land Rover (JLR) from Ford for $2.3 billion. The deal catapulted the Indian company into the club of the larg… Read More
Banks target Sintex, NBFCs for insolvency proceedingsThe move to initiate insolvency proceedings follows the expiry of the six-month deadline for resolving the default in respect of these companies. In terms of the RBI’s June 2019 circular, banks are required to make additional… Read More
0 Comments:
Post a Comment